Article
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
Journal of translational medicine - 1 Jun 2018
Moll Solange, Yasui Yukari, Abed Ahmed, Murata Takeshi, Shimada Hideaki, Maeda Akira, Fukushima Naoshi, Kanamori Masakazu, Uhles Sabine, Badi Laura, Cagarelli Thomas, Formentini Ivan, Drawnel Faye, Georges Guy, Bergauer Tobias, Gasser Rodolfo, Bonfil R Daniel, Fridman Rafael, Richter Hans, Funk Juergen, Moeller Marcus J, Chatziantoniou Christos, Prunotto Marco
Abstract excerpt
BACKGROUND: Discoidin domain receptor 1 (DDR1) is a collagen-activated receptor tyrosine kinase extensively implicated in diseases such as cancer, atherosclerosis and fibrosis. Multiple preclinical studies, performed using either a gene deletion or a gene silencing approaches, have shown this receptor being a major driver target of fibrosis and glomerulosclerosis. METHODS: The present study investigated the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
